These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6786403)

  • 1. Antifibrillatory efficacy of encainide, loracainide and ORG 6001 compared with lignocaine in isolated hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    Br J Pharmacol; 1981 Jun; 73(2):373-7. PubMed ID: 6786403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
    Carmeliet E
    Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of the antifibrillatory activity of flunarizine and lidoflazine in isolated hearts of rabbits and guinea pigs.
    Almotrefi AA
    Fundam Clin Pharmacol; 1990; 4(5):503-10. PubMed ID: 2289743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ
    Eur Heart J; 1984 Sep; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract]   [Full Text] [Related]  

  • 6. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effects of lignocaine and lorcainide on conduction in the Langendorff-perfused guinea-pig heart.
    Carmeliet E; Zaman MY
    Cardiovasc Res; 1979 Aug; 13(8):439-49. PubMed ID: 90549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
    Campbell TJ; Hemsworth PD
    Clin Exp Pharmacol Physiol; 1990 Feb; 17(2):135-45. PubMed ID: 2158404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of procainamide, tocainide and lorcainide on Na(+)-K(+)-ATPase in guinea pig heart preparations.
    Dzimiri N; Almotrefi AA
    Gen Pharmacol; 1991; 22(2):403-6. PubMed ID: 1647350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G; Serruys PW; Hugenholtz PG
    Eur Heart J; 1984 Sep; 5 Suppl B():67-74. PubMed ID: 6437819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quinidine, lidocaine and encainide on guinea pig myocardial Na(+)-K(+)-ATPase activity.
    Almotrefi AA; Dzimiri N
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):253-6. PubMed ID: 2168576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations.
    Almotrefi AA; Dzimiri N
    Br J Pharmacol; 1991 Feb; 102(2):530-2. PubMed ID: 1849773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG
    Eur Heart J; 1984 Sep; 5 Suppl B():63-6. PubMed ID: 6437818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of encainide (MJ9067) on the ventricular fibrillation threshold in anesthetized dogs.
    Jaillon P; de la Rosa S; Griffin JC; Winkle RA; Harrison DC
    J Cardiovasc Pharmacol; 1980; 2(5):517-26. PubMed ID: 6157946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of class I antiarrhythmic drugs on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA
    Gen Pharmacol; 1993 Jan; 24(1):233-7. PubMed ID: 8482500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ; Winkle RA
    Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative antiarrhythmic actions of encainide and its major metabolites.
    Gomoll AW; Byrne JE; Mayol RF
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):277-97. PubMed ID: 3092755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.